Technology Research Personalized Treatment Glucose Monitoring & Insulin Delivery Therapeutic Discovery and Development

AACE 2026: AI moves from hype to reality in diabetes care

"Right now, AI is more of a copilot, but the long-term vision is something much closer to autopilot."

April 23, 2026 By Matthew Solan 4 min read
Share

5 Key Takeaways

  • 1

    AI is transforming diabetes care by utilizing high-frequency data from devices like CGMs and automated insulin delivery systems.

  • 2

    AI-supported insulin titration improves patient adherence and efficiency in reaching target doses compared to standard care.

  • 3

    AI can analyze CGM data to identify meaningful patterns, aiding in personalized diabetes management strategies.

  • 4

    AI-driven lifestyle interventions show comparable outcomes to traditional programs, enhancing patient engagement and adherence.

  • 5

    While fully autonomous AI in diabetes management is a future goal, current systems serve as effective assistive tools for clinicians.

AACE Endocrine AI is published by Conexiant under a license arrangement with the American Association of Clinical Endocrinology, Inc. (AACE®). The ideas and opinions expressed in AACE Endocrine AI do not necessarily reflect those of Conexiant or AACE. For more information, see Policies.

Related Content